A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors (vol 104, pg 4071, 2007)
- Author(s)
- Scott, AM; Lee, FT; Tebbutt, N; Herbertson, R; Gill, SS; Liu, ZQ; Skrinos, E; Murone, C; Saunder, TH; Chappell, B; Papenfuss, AT; Poon, AMT; Hopkins, W; Smyth, FE; MacGregor, D; Cher, LM; Jungbluth, AA; Ritter, G; Brechbiel, MW; Murphy, R; Burgess, AW; Hoffman, EW; Johns, TG; Old, LJ;
- Details
- Publication Year 2007-10-02,Volume 104,Issue #40,Page 15965-15965
- Journal Title
- PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Publication Type
- Journal Article
- Publisher
- NATL ACAD SCIENCES
- Publisher's Version
- https://doi.org/10.1073/pnas.0708144104
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2007-10-02 12:00:00